LYSARC is an independent, non-profit organization.
The protection of patients is a top priority for LYSARC. We submit our study protocols and informed consent forms to cancer patient committees, in cooperation with the French Ligue Against Cancer and according to the recommendations of France’s 2014-2019 Cancer Plan. Our data and biological collections are declared in compliance with regulations.
Our studies in progress are posted on different specialized websites, including that of the French National Cancer Institute (INCa) US National Institute of Health and the LYSA website. Active trials can also been found on the online application ClinTrial Refer LYSA.